RESEARCHER PROFILE
JC Orengo
← Back to Ponce Health Sciences University
J
Ponce Health Sciences University
JC Orengo works in Breast Cancer Treatment Studies, Microtubule and mitosis dynamics, Cancer Cells and Metastasis, Cervical Cancer and HPV Research, Global Cancer Incidence and Screening. Recorded institutional associations include Ponce Health Sciences University.
16Publications
14Citations
1H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Mitotic kinases are emerging therapeutic targets against metastatic breast cancer
2024 · 13 citationsPCV39 THE PUERTO RICO CARDIOVASCULAR RISK ESTIMATION STUDY (PRCARES): AN EXPLORATORY ASSESSMENT OF NEW PATIENTS IN PHYSICIANS' OFFICES
2010 · 1 citationsThe Burden of Cancer in Jamaica
2015 · 0 citationsGeographic distribution of risk of death due to homicide in Puerto Rico, 2000–2007
2010 · 0 citationsChange In The Demographic Profile And Impact In The Mortality Of Melanoma And Lung Cancer In Puerto Rico 2000-2010
2015 · 0 citationsEE244 Estimating Treatment Cost Savings of Gender-Neutral Nonavalent HPV Vaccination in Mexico
2024 · 0 citationsAbstract C151: Single and combined inhibition of AURKA and AURKB promotes a decrease in the expression of EMT biomarkers and transcription factors in triple-negative breast cancer in women of African ancestry
2024 · 0 citationsAbstract C141: Inactivating the mitotic kinases TTK and NEK2 as a promising approach for the reduction of metastasis in triple-negative breast cancer in non-Hispanic Blacks and Hispanic/Latinas
2024 · 0 citationsEPH12 Hospitalization Rates of HPV-Associated Cancers in Brazil From 2011-2019
2024 · 0 citationsEPH11 Burden of HPV-Associated Cancers in Mexico From 2011-2019
2024 · 0 citationsEE211 The Indirect Costs and Burden of Vaccine Preventable Cancers Mortality in Latin American Region
2024 · 0 citationsAbstract 6949: Downregulating the mitotic kinases TTK and NEK2 as a promising approach for the reduction of metastasis in triple-negative breast cancer cell lines
2025 · 0 citationsAbstract 5456: Multiplatform bioinformatic profiling identifies TTK and NEK2 as survival-associated drivers in triple-negative breast cancer.
2026 · 0 citationsAbstract 7165: The role of NEK2 and AURKB on triple-negative breast cancer progression
2026 · 0 citationsAbstract 320: Targeting overexpressed TTK and NEK2 decreases early metastatic potential of triple-negative breast cancer cell lines.
2026 · 0 citationsAbstract 333: Downregulation of AURKA and AURKB promotes a decrease in cell invasion in TNBC by modulating the expression of SNAIL1.
2026 · 0 citations
